Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment (2010)
- Authors:
- USP affiliated authors: FUKUI, ROSA TSUNECHIRO - FM ; ROCHA, DALVA MARREIRO - FM
- Unidade: FM
- Subjects: DIABETES MELLITUS; GLICEMIA (CONTROLE); INSULINA (APLICAÇÕES TERAPÊUTICAS); RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
NOGUEIRA, K C et al. Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 19 abr. 2024. , 2010 -
APA
Nogueira, K. C., Fukui, R. T., Rossi, D. M., Rocha, D. M., Santos, R. F., & Silva, M. E. R. (2010). Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Nogueira KC, Fukui RT, Rossi DM, Rocha DM, Santos RF, Silva MER. Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment. Clinics. 2010 ; 65 S46-S47.[citado 2024 abr. 19 ] -
Vancouver
Nogueira KC, Fukui RT, Rossi DM, Rocha DM, Santos RF, Silva MER. Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment. Clinics. 2010 ; 65 S46-S47.[citado 2024 abr. 19 ] - Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study
- Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients
- Non-Islet Autoantibodies (Non-IsletAAb): Prevalence and Association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients
- Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
- Efeitos benéficos da associação de rosiglitazona ou metformina à glibenclamida no controle Glicêmico e risco cardiovascular
- Genetic Association of the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) and Type 1 Diabetes in Brazil
- Resposta terapêutica ao uso de rosiglitazona ou nateglinida em diabéticos do tipo 2.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
